Observation on Bayaspirin combined with Simvastati in the treatment of cerebral thrombosis
Suwen Li, Danping Zheng, Minling Chen
Abstract
Suwen Li, Danping Zheng, Minling Chen
Abstract
Objective To investigate the clinical efficacy of Bayaspirin combined with Simvastatin in the treatment of cerebral thrombosis.Methods 112 patients with cerebral thrombosis were divided into 56 cases in the control group and 56 cases in the treatment group.Control group:Bayaspirin 0.1g,1 time/day; 1 placebo tablet,1 time/night,14 days for 1 period of treatment.Treatment group:Bayaspirin 0.1g,1 time/day ; Simvastatin 20 mg,1 time/night,14 days for 1 period of treatment.The clinical efficacy in the two groups was compared.Results The total effective rate was 87.50% in the control group and 94.64% in the treatment group,the difference in the two groups was statistically significant (P < 0.05).Conclusion Bayaspirin combined with Simvastatin can significantly improve the clinical symptoms and signs of patients with cerebral thrombosis,promote the recovery of neurological function.No adverse reaction was found. Key words: Bayaspirin; Simvastatin; Efficacy
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the clinical efficacy of Bayaspirin combined with Simvastatin in the treatment of cerebral thrombosis.Methods 112 patients with cerebral thrombosis were divided into 56 cases in the control group and 56 cases in the treatment group.Control group:Bayaspirin 0.1g,1 time/day; 1 placebo tablet,1 time/night,14 days for 1 period of treatment.Treatment group:Bayaspirin 0.1g,1 time/day ; Simvastatin 20 mg,1 time/night,14 days for 1 period of treatment.The clinical efficacy in the two groups was compared.Results The total effective rate was 87.50% in the control group and 94.64% in the treatment group,the difference in the two groups was statistically significant (P < 0.05).Conclusion Bayaspirin combined with Simvastatin can significantly improve the clinical symptoms and signs of patients with cerebral thrombosis,promote the recovery of neurological function.No adverse reaction was found. Key words: Bayaspirin; Simvastatin; Efficacy
Key concepts: Cerebral thrombosis, Simvastatin, Medicine, Clinical efficacy, Thrombosis, Anesthesia, Placebo, Treatment and control groups